Replies to post #390788 on Amarin Corp Plc (AMRN)

[rosemountbomber]

Thanks Raf. We are hanging in there.

[Number sleven]

Raf, Thanks for the numbers.
Sleven,

[mrmainstreet]

I would really like to see KM increase the exclusive agreements beyond 45% of the market. It's stabilized our scripts and provided much needed cash flow, but it would be a huge positive if he could get more on board with shutting out the generics.

[wodehouse]

What is fake Vascepa? Generics?

[Nukemtiltheyglow]

Thanks Raf

[rafunrafun]

Scripts for week ending October 14, 2022

Drug Industry TRx: -1.9% w/w; +7.0% y/y

Vascepa
TRx 62,515; -3.0% (-1,962) w/w; -20.9% y/y
NRx 28,052; -5.2% (-1,549) w/w; -21.0% y/y
Ref 34,463; -1.2% (-413) w/w; -20.9% y/y

Fake Vascepa
TRx 39,895; -0.7% (-263) w/w; As % of total V: 39.0%
NRx 18,936; -4.3% (-860) w/w; As % of total V: 40.3%
Ref 20,958; +2.9% (+587) w/w; As % of total V: 37.8%

Fake Vascepa by Manufacturer
Hikma - TRx 14,614; +617 w/w; Generic share 36.6%; Total V share 14.3%
Reddy - TRx 17,713; -928 w/w; Generic share 44.4%; Total V share 17.3%
Apotex - TRx 7,379; +25 w/w; Generic share 18.5%; Total V share 7.2%
Teva - TRx 189; +24 w/w; Generic share 0.5%; Total V share 0.2%

Vascepa + Fake Vascepa
TRx 102,410; -2.1% (-2,225) w/w; +3.0% y/y
NRx 46,988; -4.9% (-2,409) w/w; -0.3% y/y
Ref 55,042; +0.3% (+184) w/w; +5.9% y/y

Lovaza (Fake & Brand)
TRx 62,249; -3.2% (-2,042) w/w; +0.8% y/y
NRx 30,272; -2.0% (-607) w/w; +1.6% y/y
Ref 31,977; -4.3% (-1,445) w/w; +0.0% y/y